Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents

Journal of Child and Adolescent Psychopharmacology

Volumn 22, Issue 3, 2012, Pages 238-244

  Adler, Lenard A ^a,b   Shaw, David M ^a   Spencer, Thomas J ^c,d   Newcorn, Jeffrey H ^e   Hammerness, Paul ^d   Sitt, David J ^f   Minerly, Christina ^g   Davidow, Jennifer V ^e   Faraone, Stephen V ^h  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f CITY UNIVERSITY OF NEW YORK   (United States)

^g CITY UNIVERSITY OF NEW YORK   (United States)

^h State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; PSYCHOSTIMULANT AGENT;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DEFICIT HYPERACTIVITY DISORDER RATING SCALE; ATTENTION DEFICIT HYPERACTIVITY DISORDER SELF REPORT SCALE V1.1 SYMPTOM CHECKLIST; CLINICAL EXAMINATION; CONCURRENT VALIDITY; CORRELATION COEFFICIENT; DSM-IV-TR; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERNAL CONSISTENCY; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; RATING SCALE; RELIABILITY;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SELF REPORT;

EID: 84862494382     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2011.0062     Document Type: Article

References (38)

1. Adler L, Cohen J: Diagnosis and evaluation of adults with attentiondeficit/hyperactivity disorder. Psychiatr Clin North Am 27:187-201, 2004. (Pubitemid 38452762)
2. Adler LA, Shaw DM, Spencer TJ, Newcorn JH, Hammerness P, Sitt DJ, Davidow JV, Faraone SV: Reliability of the ADHD Self Report Scale (ASRS) v1.1 Symptom Checklist to Rate Adolescent ADHD Symptoms. Paper presented at the 57th Annual Meeting of the American Academy of Child and Adolescent Psychiatry in New York, NY in 2010.
3. Adler LA, Spencer T, Brown TE, Holdnack J, Saylor K, Schuh K, Trzepacz PT, Williams DW, Kelsey D: Once-daily atomoxetine for adult attention-deficit/ hyperactivity disorder: A 6-month, double-blind trial. J Clin Psychopharmacol 29:44-50, 2009.
4. Adler LA, Spencer T, Faraone SV, Kessler RC, Howes M, Biederman J, Secnik K: Validity of pilot adult ADHD self-report scale (ASRS) to rate adult ADHD symptoms. Ann Clin Psychiatry 18:145-148, 2006. (Pubitemid 44576434)
5. Adler LA, Spencer T, Faraone SV, Reimherr FW, Kelsey D, Michelson D, Biederman J: Training raters to assess adult ADHD: reliability of ratings. J Atten Disord 8:121-126, 2005. (Pubitemid 40805795)
6. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
7. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
8. Barkley RA, Anastopoulos AD, Guevremont DC, Fletcher KE: Adolescents with ADHD: Patterns of behavioral adjustment, academic functioning, and treatment utilization. J Am Acad Child Adolesc Psychiatry 30:752-761, 1991.
9. Barkley RA, Fischer M, Edelbrock CS, Smallish L: The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 29:546-557, 1990. (Pubitemid 20235340)
10. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C, Sprich-Buckminster S, Ugaglia K, Jellinek MS, Steingard R, Spencer T, Norman D, Kolodny R, Kraus I, Perrin J, Keller MB, Tsuang MT: Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder, patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 49:728-738, 1992.
11. Biederman J, Faraone SV, Milberger S, Jetton JG, Chen L, Mick E, Greene RW, Russell RL: Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a fouryear follow-up study of children with ADHD. J Am Acad Child Adolesc Psychiatry 35:1193-1204, 1996. (Pubitemid 26282600)
12. Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL: Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther 29:450-463, 2007. (Pubitemid 46924786)
13. Biederman J, Newcorn J, Sprich S: Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148:564-577, 1991.
14. Brown TE: Attention-Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. Washington, DC: American Psychiatric Press; 2000.
15. Conners CK: Conners' Rating Scale-Revised: Technical Manual. New York: Multi-Health Systems, Inc.; 1997.
16. Cronbach LJ: Coefficient alpha and the internal consistency of tests. Psychometrika 16:297-334, 1951.
17. Dulcan M: Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 36(Suppl 10):85S-121S, 1997.
18. DuPaul GJ, George J, Power TJ, Anastopoulos AD: ADHD Rating Scale - IV: Checklists, Norms, and Clinical Interpretation. New York: The Guilford Press; 1998.
19. Faraone SV, Sergeant J, Billberg C, Biederman J: The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2:104-113, 2003.
20. Faries DE, Yalcin I, Harder D, Heiligenstein JH: Validation of the ADHD Rating Scale as a clinician administered and scored instrument. J Atten Disord 5:107-115, 2001. (Pubitemid 33794656)
21. Findling RL, Childress AC, Cutler AJ, Gasior M, Hamdani M, Ferreira-Cornwell MC, Squires L: Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 50:395-405, 2011.
22. Findling RL, Childress AC, Krishnan S, McGough JJ: Long-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. CNS Spectr 13:614-620, 2008.
23. Goodman DW, Lasser RA, Babcock T, Pucci ML, Solanto MV: Managing ADHD across the lifespan in the primary care setting. Postgrad Med 123:14-26, 2011.
24. Hollingshead AB: Four Factor Index of Social Status. New Haven, CT: Yale University Press; 1975.
25. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997. (Pubitemid 27272932)
26. Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ: Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial. Pediatrics 114:e1-e8, 2004.
27. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, Ustun TB, Walters EE: The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population. Psychol Med 35:245-256, 2005. (Pubitemid 40259916)
28. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ: The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry 163:716-723, 2006. (Pubitemid 44464584)
29. Kessler RC, Green JG, Adler LA, Barkley RA, Chatterji S, Faraone SV, Finkelman M, Greenhill LL, Gruber MJ, Jewell M, Russo LJ, Sampson NA, Van Brunt DL: Structure and diagnosis of adult attention-deficit/hyperactivity disorder: Analysis of expanded symptom criteria from the adult ADHD clinical diagnostic scale. Arch Gen Psychiatry 67:1168-1178, 2010.
30. Mannuzza S, Klein RG. 1999. Adolescent and adult outcomes in attention-deficit/hyperactivity disorder (Trans.). In: Adolescent and Adult Outcomes in Attention-Deficit/Hyperactivity Disorder. Edited by H.C. Quay, A.E. Hogan. New York: Kluwer Academic/Plenum Publishers; pp. 279-294.
31. Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T, Atomoxetine ADHD Study Group: Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, doseresponse study. Pediatrics 108:E83, 2001.
32. Millstein RB, Wilens TE, Biederman J, Spencer TJ: Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD. J Atten Disord 2:159-166, 1997. (Pubitemid 127729777)
33. Murphy KR, Adler LA: Assessing attention-deficit/hyperactivity disorder in adults: Focus on rating scales. J Clin Psychiatry 65:12-17, 2004.
34. Spencer T, Heiligenstein JH, Biederman J, Faries DE, Kratochvil CJ, Conners CK, Potter WZ: Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry 63:1140-1147, 2002. (Pubitemid 36084059)
35. The MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086, 1999.
36. Weiss M, Jain U: Clinical perspectives on the assessment of ADHD in adolescence. ADHD Rep 8:4-10, 2000.
37. Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM: Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 160:82-90, 2006a. (Pubitemid 43042140)
38. Wilens TE, Newcorn JH, Kratochvil CJ, Gao H, Thomason CK, Rogers AK, Feldman PD, Levine LR: Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. J Pediatr 67:696-702, 2006b.